Search Results for
GI008Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Continue Reading »NSABP C-14
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Continue Reading »EA2201
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer
Continue Reading »MK-7339-003
Efficacy and Safety of Olaparib, Olaparib + Bevacizumab Compared to Bevacizumab + 5-Fluorouracil (FU)
Continue Reading »NRG-GI005
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
Continue Reading »S1820
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors
Continue Reading »WF-1806
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Continue Reading »A021502
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Continue Reading »